Changes in the Long-term Prognosis of Crohn’s Disease between 1986 and 2015: The Population-Based Songpa-Kangdong Inflammatory Bowel Disease Cohort Study
2
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Background/Aims: The long-term course of Crohn’s disease (CD) has never been evaluated in non-Caucasian population-based cohorts. The aim of the present study was to evaluate the longterm prognosis of Korean CD patients in the well-defined population-based Songpa-Kangdong inflammatory bowel disease cohort. Methods: Outcomes of disease and their predictors were evaluated for 418 patients diagnosed with CD between 1986 and 2015. Results: During a median of 123 months, systemic corticosteroids, thiopurines, and anti-tumor necrosis factor (TNF) agents were administered to 58.6%, 81.3%, and 37.1% of patients, respectively. Over time, the cumulative probability of starting corticosteroids significantly decreased (p=0.001), whereas that of starting thiopurines and anti-TNFs significantly increased (both p<0.001). The cumulative probability of behavioral progression was 54.5% at 20 years, and it significantly decreased during the anti-TNF era. Intestinal resection was required for 113 patients (27.0%). The cumulative probabilities of intestinal resection at 1, 5, 10, 20, and 25 years after CD diagnosis were 12.7%, 16.5%, 23.8%, 45.1%, and 51.2%, respectively. Multivariable Cox regression analysis identified stricturing behavior at diagnosis (adjusted hazard ratio [aHR], 2.70; 95% confidence interval [CI], 1.55 to 4.71), penetrating behavior at diagnosis (aHR, 11.15; 95% CI, 6.91 to 17.97), and diagnosis of CD during the anti-TNF era (aHR, 0.51; 95% CI, 0.35 to 0.76) as independently associated with intestinal resection. The standardized mortality ratio among CD patients was 1.36 (95% CI, 0.59 to 2.68). Conclusions: The long-term prognosis of Korean patients with CD is at least as good as that of Western CD patients, as indicated by the low intestinal resection rate. Moreover, behavioral progression and intestinal resection rates have decreased over the past 3 decades.
Abstract
Background/Aims: The long-term course of Crohn’s disease (CD) has never been evaluated in non-Caucasian population-based cohorts. The aim of the present study was to evaluate the longterm prognosis of Korean CD patients in the well-defined population-based Songpa-Kangdong inflammatory bowel disease cohort. Methods: Outcomes of disease and their predictors were evaluated for 418 patients diagnosed with CD between 1986 and 2015. Results: During a median of 123 months, systemic corticosteroids, thiopurines, and anti-tumor necrosis factor (TNF) agents were administered to 58.6%, 81.3%, and 37.1% of patients, respectively. Over time, the cumulative probability of starting corticosteroids significantly decreased (p=0.001), whereas that of starting thiopurines and anti-TNFs significantly increased (both p<0.001). The cumulative probability of behavioral progression was 54.5% at 20 years, and it significantly decreased during the anti-TNF era. Intestinal resection was required for 113 patients (27.0%). The cumulative probabilities of intestinal resection at 1, 5, 10, 20, and 25 years after CD diagnosis were 12.7%, 16.5%, 23.8%, 45.1%, and 51.2%, respectively. Multivariable Cox regression analysis identified stricturing behavior at diagnosis (adjusted hazard ratio [aHR], 2.70; 95% confidence interval [CI], 1.55 to 4.71), penetrating behavior at diagnosis (aHR, 11.15; 95% CI, 6.91 to 17.97), and diagnosis of CD during the anti-TNF era (aHR, 0.51; 95% CI, 0.35 to 0.76) as independently associated with intestinal resection. The standardized mortality ratio among CD patients was 1.36 (95% CI, 0.59 to 2.68). Conclusions: The long-term prognosis of Korean patients with CD is at least as good as that of Western CD patients, as indicated by the low intestinal resection rate. Moreover, behavioral progression and intestinal resection rates have decreased over the past 3 decades.
참고문헌 (37)
- Kaplan GG, "Understanding and preventing the global increase of inflammatory bowel disease", Gastroenterology, 152, pp.313~321 (2017)
- Ananthakrishnan AN, "Changing global epidemiology of inflammatory bowel diseases : sustaining health care delivery into the 21st century", Clin Gastroenterol Hepatol, 18, pp.1252~1260 (2020)
- Jamilya Kaibullayeva, "Prevalence and patient awareness of inflammatory bowel disease in Kazakhstan: a cross-sectional study", Intestinal research, 18(4), pp.430~437 (2020), 대한장연구학회[DOI]
- Park SH, "A 30-year trend analysis in the epidemiology of inflammatory bowel disease in the Songpa-Kangdong district of Seoul, Korea in 1986-2015", J Crohns Colitis, 13, pp.1410~1417 (2019)
- Liu JZ, "Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations", Nat Genet, 47, pp.979~986 (2015)
- Hong M, "Immunochip meta-analysis of inflammatory bowel disease identifies three novel loci and four novel associations in previously reported loci", J Crohns Colitis, 12, pp.730~741 (2018)
- Yang SK, "Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005 : a KASID study", Inflamm Bowel Dis, 14, pp.542~549 (2008)
- Ye BD, "Clinical features and longterm prognosis of Crohn’s disease in Korea", Scand J Gastroenterol, 45, pp.1178~1185 (2010)
- Zeng Z, "Incidence and clinical characteristics of inflammatory bowel disease in a developed region of Guangdong Province, China : a prospective populationbased study", J Gastroenterol Hepatol, 28, pp.1148~1153 (2013)
- Park SH, "Long-term prognosis of Crohn’s disease and its temporal change between 1981 and 2012 : a hospital-based cohort study from Korea", Inflamm Bowel Dis, 20, pp.488~494 (2014)
- Hsu-Heng Yen, "Epidemiological trend in inflammatory bowel disease in Taiwan from 2001 to 2015: a nationwide population-based study", Intestinal research, 17(1), pp.54~62 (2019), 대한장연구학회[DOI]
- Yang SK, "How does the epidemiology of inflammatory bowel disease differ between east and west? A Korean perspective", Inflamm Intest Dis, 2, pp.95~101 (2017)
- Oriuchi T, "Clinical course and longterm prognosis of Japanese patients with Crohn’s disease : predictive factors, rates of operation, and mortality", J Gastroenterol, 38, pp.942~953 (2003)
- Siddique I, "Clinical epidemiology of Crohn’s disease in Arabs based on the Montreal classification", Inflamm Bowel Dis, 18, pp.1689~1697 (2012)
- Goel A, "Clinical profile and predictors of disease behavior and surgery in Indian patients with Crohn’s disease", Indian J Gastroenterol, 32, pp.184~189 (2013)
- Aljebreen AM, "Clinical epidemiology and phenotypic characteristics of Crohn’s disease in the central region of Saudi Arabia", Saudi J Gastroenterol, 20, pp.162~169 (2014)
- Kim HJ, "Incidence and natural course of inflammatory bowel disease in Korea, 2006-2012 : a nationwide population-based study", Inflamm Bowel Dis, 21, pp.623~630 (2015)
- Ng SC, "Early course of inflammatory bowel disease in a population-based inception cohort study from 8 countries in Asia and Australia", Gastroenterology, 150, pp.86~95 (2016)
- Ng SC, "Epidemiology of inflammatory bowel disease from 1981 to 2014 : results from a territory-wide population-based registry in Hong Kong", Inflamm Bowel Dis, 22, pp.1954~1960 (2016)
- Loftus EV Jr, "Crohn’s disease in Olmsted County, Minnesota, 1940-1993 : incidence, prevalence, and survival", Gastroenterology, 114, pp.1161~1168 (1998)
- Lee YJ, "Analysis of colonoscopic findings in the differential diagnosis between intestinal tuberculosis and Crohn’s disease", Endoscopy, 38, pp.592~597 (2006)
- Silverberg MS, "Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology", Can J Gastroenterol, 19(Suppl A), pp.5A~36A (2005)
- Burisch J, "Natural disease course of Crohn’s disease during the first 5 years after diagnosis in a European population-based inception cohort : an Epi-IBD study", Gut, 68, pp.423~433 (2019)
- Ramadas AV, "Natural history of Crohn’s disease in a population-based cohort from Cardiff(1986-2003) : a study of changes in medical treatment and surgical resection rates", Gut, 59, pp.1200~1206 (2010)
- Lakatos PL, "Has there been a change in the natural history of Crohn’s disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009", Am J Gastroenterol, 107, pp.579~588 (2012)
- Jeuring SF, "Improvements in the long-term outcome of Crohn's disease over the past two decades and the relation to changes in medical management : results from the population-based IBDSL cohort", Am J Gastroenterol, 112, pp.325~336 (2017)
- Choon Jin Ooi, "Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn’s disease in Asia", Intestinal research, 17(3), pp.285~310 (2019), 대한장연구학회[DOI]
- Hanauer SB, "Crohn’s disease : step up or top down therapy", Best Pract Res Clin Gastroenterol, 17, pp.131~137 (2003)
- Wolfe RA, "The standardized mortality ratio revisited : improvements, innovations, and limitations", Am J Kidney Dis, 24, pp.290~297 (1994)
- "Number of deaths and death rate by cause of death (103 items)/sex/age (5 years old)" (2020)[URL]
- Rungoe C, "Changes in medical treatment and surgery rates in inflammatory bowel disease : a nationwide cohort study 1979-2011", Gut, 63, pp.1607~1616 (2014)
- Jin Young Yoon, "Effects of Perianal Involvement on Clinical Outcomes in Crohn’s Disease over 10 Years", Gut and Liver, 12(3), pp.297~305 (2018), 거트앤리버 소화기연관학회협의회
- Jaeyoung Chun, "Association of Perianal Fistulas with Clinical Features and Prognosis of Crohn’s Disease in Korea: Results from the CONNECT Study", Gut and Liver, 12(5), pp.544~554 (2018), 거트앤리버 소화기연관학회협의회
- Murthy SK, "Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases : a population-based interrupted time series study", Gut, 69, pp.274~282 (2020)
- Frolkis AD, "Risk of surgery for inflammatory bowel diseases has decreased over time : a systematic review and meta-analysis of population-based studies", Gastroenterology, 145, pp.996~1006 (2013)
- Thia KT, "An update on the epidemiology of inflammatory bowel disease in Asia", Am J Gastroenterol, 103, pp.3167~3182 (2008)
- Wee Khoon Ng, "Changing epidemiological trends of inflammatory bowel disease in Asia", Intestinal research, 14(2), pp.111~119 (2016), 대한장연구학회